Femme Homme
- | Pays :
- New Zealand
- Australia
- United States
- | Organes : -
- | Spécialités : -
Extrait
This phase I/II trial will determine the recommended dose and activity of BNC105P for patients with partially platinum sensitive ovarian cancer in first or second relapse.
Critère d'inclusion
- Ovarian Cancer